Search Within

Survivorship Research

Formats
  1. Journal Article (9005)
  2. Meeting Abstract (5248)
  3. Book Section (579)
  4. Review (366)
  5. Editorial (234)
  6. Research Letter (138)
  7. Conference Paper (104)
  8. Correspondence (92)
  9. Guidelines (90)
  10. Miscellaneous (78)
  11. Book Whole (30)
Groups
  1. Department of Medicine (9325)
  2. Population Sciences Research Program (5753)
  3. Solid Tumor Oncology Division (5244)
  4. Surgery (5200)
  5. Epidemiology and Biostatistics (3666)
  6. Division of Subspecialty Medicine (3268)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (792)
  3. Michael Zelefsky (755)
  4. Sergio Giralt (702)
  5. Mark Robson (682)
  6. Joachim Yahalom (634)

More People

Years
  1. 2025 (384)
  2. 2024 (844)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (933)

More Years

Publications
  1. Journal of Clinical Oncology (1892)
  2. International Journal of Radiation Oncology, Biology, Physics (912)
  3. Blood (723)
  4. Annals of Surgical Oncology (602)
  5. Cancer (334)
  6. Cancer Research (333)

More Publications

Publishers
  1. Elsevier Inc. (2394)
  2. American Society of Clinical Oncology (2041)
  3. Springer (1558)
  4. Wiley Blackwell (817)
  5. Oxford University Press (792)
  6. American Society of Hematology (790)

More Publishers

Results (15964)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; Garcés, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A high-fiber dietary intervention (NUTRIVENTION) in precursor plasma cell disorders improves biomarkers of disease and may delay progression to myeloma
    Meeting Abstract

    Shah, U. A.; Cogrossi, L. L.; Derkach, A.; Castro, F.; Fei, T.; DeWolf, S.; Garces, J. J.; Policastro, A.; Grioni, M.; Sisti, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
    Meeting Abstract

    Moskowitz, A.; Shah, G. L.; Ganesan, N.; Chang, T.; Drill, E.; Davey, T.; Hancock, H.; Munayirji, B.; Douglas, M.; Santarosa, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-term follow up of a prospective pilot study of an α/β T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Hughes, C. F. M.; Lin, R. J.; Devlin, S. M.; Shaffer, B. C.; Jakubowski, A. A.; Talla, V.; Saldia, A.; Gyurkocza, B.; Papadopoulos, E. B.; Giralt, S. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Relationship of physical activity and cognitive functioning among breast cancer survivors: A cross-sectional analysis
    Journal Article

    Hartman, S. J.; Zablocki, R. W.; Tam, R. M.; Palmer, B. W.; Parker, B. A.; Sears, D. D.; Ahles, T. A.; Natarajan, L.
    Frontiers in Cognition (2024)

    Fulltext@MSK | Save
  • 24-hour urine testing does not add value to multiple myeloma response assessments: A secondary analysis of BMT CTN 0702
    Meeting Abstract

    Banerjee, R.; Fritz, A. R.; Akhtar, O. S.; Freeman, C. L.; Cowan, A. J.; Shah, N.; Landau, H. J.; Kumar, S.; Vogl, D. T.; Efebera, Y. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Technical innovations and new therapies to optimize functional outcomes after radiation therapy
    Book Section

    Kollmeier, M.; Silver, B.
    In Razdan, S.; Razdan, S. (Eds.) Urinary Continence and Sexual Function after Robotic Prostatectomy, Radiation, and Novel Therapies. 2nd ed (2024)

    Fulltext@MSK | Save
  • Mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed and/or refractory follicular lymphoma after ≥ 2 prior therapies including those with a history of POD24: 4-year follow-up of a pivotal phase II study
    Meeting Abstract

    Shadman, M.; Bartlett, N. L.; Matasar, M.; Schuster, S. J.; Assouline, S. E.; Sehn, L. H.; Kuruvilla, J.; Giri, P.; Cheah, C. Y.; Dietrich, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Screening for AL amyloidosis in smoldering multiple myeloma
    Meeting Abstract

    Toskic, D.; Mansukhani, M.; Zhou, P.; Scalia, S.; Ma, X.; Fogaren, T.; Lee, L. X.; Chung, A.; Tuchman, S. A.; Bianchi, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save